Promoting and Expanding Sales of Orthokeratology Lenses

「For the orthokeratology lens “Breath-O Correct,” for which approval for an effect in suppressing myopia progression is being pursued, we will continue seeking to expand sales by increasing the number of facilities offering the product.」

「For the orthokeratology lens “Breath-O Correct®,” we are expanding existing services and promoting adoption through academic communications, including seminars held at various academic conferences, while selling the product with the aim of increasing market share. Orthokeratology lenses, which are worn during sleep to correct vision during the day without glasses or contact lenses, grew substantially, up 21.4% from the previous fiscal year.」

「We are expanding adoption of the orthokeratology lens “Breath-O Correct®” through academic communications, including seminars held at various academic conferences, and selling the product with the aim of increasing market share. Orthokeratology lenses, which are worn during sleep to correct vision during the day without glasses or contact lenses, grew substantially, up 22.2% year on year.」

「Orthokeratology lenses grew substantially, up 15.5% year on year.」

「Approval was obtained for the orthokeratology lenses for which an application had been filed by the joint venture, and supplies of materials for manufacturing orthokeratology lenses in China consequently commenced. Orthokeratology lenses, which are worn during sleep to correct vision during the day without glasses or contact lenses, grew substantially, up 14.9% year on year.」

「Orthokeratology lenses, which are worn during sleep to correct vision during the day without glasses or contact lenses, grew substantially, up 13.0% year on year.」

「The orthokeratology lens market showed steady growth, with sales increasing substantially by 23.8% from the previous fiscal year, while progressive contact lenses also grew substantially, up 19.2% from the previous fiscal year.」

「We have focused on expanding sales of high-value-added products, including progressive contact lenses, for which particularly strong market growth is expected, and medical orthokeratology lenses. The orthokeratology lens market showed steady growth, with sales increasing 20.9% year on year, while progressive contact lenses also grew substantially, up 16.9% year on year.」

「The orthokeratology lens market also showed steady growth, with sales increasing substantially by 17.8% year on year.」

「We also worked to promote orthokeratology lenses, which are worn during sleep to correct vision during the day without glasses or contact lenses. Unlike other contact lenses, orthokeratology lenses are products for use under medical supervision. As a result, the One Day Pure series increased 24% year on year on stronger demand, while orthokeratology lenses also grew substantially, up 14% year on year as the market showed steady growth.」

「High-value progressive lenses increased 9.9% year on year on stronger demand. Orthokeratology lenses also grew substantially, up 32.4% year on year, as the market continued to make steady progress despite the spread of the infection. With regard to orthokeratology lenses, Universal View Co., Ltd. was absorbed in a merger on 31 March 2022.」

「As a result, overall contact lens sales performed in line with the plan, while orthokeratology increased significantly, by 41.3% year on year. In December 2021, the company decided to absorb and merge its wholly owned subsidiary and manufacturing and marketing company, 株式会社ユニバーサルビュー, with the aim of establishing a structure capable of responding quickly to product development.」

「As a result, overall contact lens sales showed a steady recovery, while orthokeratology lenses increased significantly, by 60.6% year on year. In May 2021, 株式会社ユニバーサルビュー was made a wholly owned subsidiary, and the Seed Group will focus on further expanding this market.」

「To further strengthen the product competitiveness and sales structure of the orthokeratology business, we made 株式会社ユニバーサルビュー, the manufacturing and marketing company for the orthokeratology lenses we sell, a wholly owned subsidiary effective 20 May. As a result, overall contact lens sales showed a steady recovery, while orthokeratology sales increased significantly, by 97.0% year on year.」

「Among these, the orthokeratology lens business made steady progress despite the spread of the infectious disease, increasing 27.0% year on year.」

「Although some facilities were cautious about new prescriptions and some patients refrained from visiting medical institutions from the standpoint of infection prevention in the first quarter, the orthokeratology lens business performed well from the second quarter onward following the resumption of school health examinations, increasing 18.1% year on year.」

「Although some facilities were cautious about new prescriptions and some patients refrained from visiting medical institutions from the standpoint of infection prevention, the orthokeratology lens business increased 4.9% year on year.」

「The orthokeratology lens business achieved growth of 57% over the previous year due to market growth and the strengthening of the sales structure following its appointment as the exclusive distributor of Breath-O Correct in October 2019.」

「Meanwhile, the orthokeratology lens business, in which lenses are worn before bedtime to reshape the cornea during sleep, achieved growth of 56% over the previous year as a result of becoming the exclusive distributor of Breath-O Correct in October 2019 and strengthening the sales structure, in addition to market growth.」

「Meanwhile, the orthokeratology lens business, in which lenses are worn before bedtime to reshape the cornea during sleep, significantly outperformed the previous year due to market growth and the strengthening of the sales structure.」

「Meanwhile, the orthokeratology lens business, in which lenses are worn before bedtime to reshape the cornea during sleep, performed well.」

「Strengthening the orthokeratology business under the joint commercialization agreement with TORAY INDUSTRIES,INC. and 株式会社ユニバーサルビュー」

「In Other, the promotion and expansion of orthokeratology lenses, which correct the cornea during sleep when worn before bedtime, lifted revenue to ¥323 million, up 30.0% year on year. However, increased costs for new introductions to overseas business partners and other factors resulted in an operating loss of ¥10 million, compared with an operating loss of ¥31 million in the same period of the previous year.」

「In Other, the promotion and expansion of orthokeratology lenses, which correct the cornea during sleep when worn before bedtime, lifted revenue to ¥204 million, up 23.2% year on year. However, the segment posted an operating loss of ¥1 million, compared with an operating loss of ¥19 million in the same period of the previous year.」